Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
06/1998
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/09/1998US5763211 Polynucleotide which encodes receptor polypeptide
06/09/1998US5763200 Inhibition of amylin release
06/09/1998US5763195 Method and compositions for making ACSF and ACSF antagonists
06/09/1998US5762922 Antioxidants and intracellular gluthathione raising agents for therapeutic treatments
06/09/1998US5762921 Composition and methods for the treatment of tumors
06/09/1998CA2157142C Treatment of diseases caused by sebaceous gland disorders
06/05/1998CA2223317A1 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
06/04/1998WO1998023760A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit
06/04/1998WO1998023741A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use
06/04/1998WO1998023738A2 Novel prokaryotic polynucleotides, polypeptides and their uses
06/04/1998WO1998023631A1 Novel bacterial polypeptides and polynucleotides
06/04/1998WO1998023610A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023284A1 Method of regulating nitric oxide production
06/04/1998WO1998023282A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
06/04/1998WO1998023279A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
06/04/1998WO1998023272A1 Compositions and methods for the treatment of gastrointestinal disorders
06/04/1998WO1998023268A1 Use of nitric oxide inhibitors for treating side effects of particulate drugs
06/04/1998WO1998023263A1 Ascending-dose dosage form
06/04/1998WO1998023155A1 Arthropodicidal and fungicidal cyclic amides
06/04/1998WO1998003180A3 Use of sex steroids function modulators to treat wounds and fibrotic disorders
06/04/1998DE19732323A1 Combination of vasodilator, microspheres and nitro-glycerine
06/04/1998CA2272243A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
06/04/1998CA2243944A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit
06/03/1998EP0845265A1 Mucosal preparation containing physiologically active peptide
06/03/1998EP0845034A1 Nucleic acid molecules encoding peptides having pronociceptive properties
06/03/1998EP0845032A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/03/1998EP0845007A2 Pharmaceutical composition containing inhibitors of interferon-gamma
06/03/1998EP0845006A2 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof
06/03/1998EP0844884A2 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of uterine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and for hormone replacement therapy
06/03/1998EP0844882A1 Appetite regulating compositions
06/03/1998EP0844880A2 Contraceptive combined preparation, kits containing the same and contraceptive method using this combined preparation
06/03/1998EP0844878A1 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c
06/03/1998EP0844875A2 Use of basic amino acids and derivatives for lowering ceramide levels
06/03/1998EP0844874A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF $g(a) v?$g(b) 5? MEDIATED ANGIOGENESIS
06/03/1998CN1183805A Chemokine receptos 88-2B £CKR-3| and 88C and their antibodies
06/03/1998CN1183722A Use of penciclovir for treatment of human herpes-virus-8
06/03/1998CN1183720A Method for treatment of macular degeneration
06/03/1998CN1183717A Use of R-NSAID in protective composition for treatment of colorectal cancer
06/02/1998US5760095 Method and system for effecting withdrawal from caffeine dependency
06/02/1998US5760061 Using a benzothiophene compound
06/02/1998US5760049 Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use
06/02/1998US5760047 Method for treatment of obesity using prolactin modulators and diet
06/02/1998US5760037 Derivatives of N'N'-di(aralkyl)-N,N'-di(2-azaaralkyl)alkylene diamine and the use thereof in pharmaceutical and cosmetic compostions
06/02/1998US5760024 Using cyclooxygenase inhibitors such as aspirin to promote embryo implantation
06/02/1998US5759775 Hybridization; amplification
06/02/1998US5759586 Mixture of sodium, potassium, magnesium and calcium (bi)carbonates and enzyme activators
06/02/1998US5759583 Polylactic/glycolic acid copolymer, bioactive agent and quaternary ammonium surfactant
06/02/1998US5759532 Controlled release of miotic and myriatic drugs in the anterior chamber
05/1998
05/28/1998WO1998022619A1 Metal mediated serine protease inhibitors
05/28/1998WO1998022605A1 Improved methods for transducing cells
05/28/1998WO1998022583A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION
05/28/1998WO1998022506A1 Human kdel receptor
05/28/1998WO1998022500A2 Modulation of interactions between myosin and integrins
05/28/1998WO1998022492A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998WO1998022138A1 Method for treating symptoms of diabetes
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022132A1 A method and composition for enabling passage through the blood-brain barrier
05/28/1998WO1998022128A1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
05/28/1998WO1998022114A1 A method for promoting tissue repair
05/28/1998WO1998022106A1 Pharmaceutical composition
05/28/1998WO1998022100A2 New use for 1,3-propanediol derivatives
05/28/1998WO1998022090A1 Treatment of equine laminitis
05/28/1998WO1998016184A3 Purine l-nucleosides, analogs and uses thereof
05/28/1998WO1998012328A3 Human bad polypeptides, encoding nucleic acids and methods of use
05/28/1998CA2633660A1 Method for treating symptoms of diabetes
05/28/1998CA2275438A1 Improved methods for transducing cells
05/28/1998CA2273183A1 Treatment of equine laminitis
05/28/1998CA2272545A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998CA2272280A1 A method and composition for enabling passage through the blood-brain barrier
05/28/1998CA2271954A1 Identification of bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transduction
05/28/1998CA2270407A1 Human kdel receptor
05/27/1998EP0844307A1 Candida albicans protein caYAE1
05/27/1998EP0844305A2 hRAD54
05/27/1998EP0843565A1 Coarse spray delivery of functional biologic materials
05/27/1998EP0843557A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
05/27/1998EP0843553A1 Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases
05/27/1998EP0843549A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
05/27/1998EP0786253A4 Agent for suppressing tumour growth
05/27/1998EP0726705B1 Apparatus for early embryonic in ovo injection
05/27/1998CN1183049A Oral Pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
05/27/1998CN1183048A Oral pharmaceutical dosage forms comprising a proton pump inhibitor and nsaid
05/27/1998CN1183047A Oral Pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
05/27/1998CN1183044A Pharmaceutical composition containing sucralfate
05/27/1998CN1183043A Preparation and use of sulfated oligosaccharides
05/27/1998CN1183039A Novel collagen formulations
05/26/1998US5756700 Nucleic acid encoding human signal transducer and activator of transcription 4
05/26/1998US5756664 Genetic engineering of proteins with nucleotide sequences for bones
05/26/1998US5756541 Irridiating target ocular tissue of patient with laser radiation, wherein the patient has been administered with porphyrins photoactive drugs which absorb the wavelength of the radiation, repetation of tratement increase visual acuity
05/26/1998US5756513 Adjustment of the prolactin cycle
05/26/1998US5756510 Potentiate effects of cytotoxic drugs or radiotherapy
05/26/1998US5756492 Graft survival prolongation with porphyrins
05/26/1998US5756477 Treatment of aids with complex of poly (A). poly (U)
05/26/1998US5756469 Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
05/26/1998US5756466 Inhibitors of interleukin-1β converting enzyme
05/26/1998US5756453 Use of angiogenic lipids for vascularizing tissue
05/26/1998US5756329 DNA encoding phenylalanyl tRNA synthetase from Staphylococcus aureus
05/26/1998US5756310 Culture product
05/26/1998US5756119 Aqueous carrier containing active ingredient, nonionic polyacrylamide predispersed in water-immiscible oil containing surfactant
1 ... 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 ... 1151